| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
Aetna
| Professional | $556.14 | $587.91 | $651.48 | |
BCBS
| Facility | $0.02 | $1,629.15 | $1,839.24 | |
United
| Professional | $333.69 | $476.69 | $1,145.89 |
Oncology (minimal residual disease [MRD]), next-generation targeted sequencing analysis of a patient-specific panel, cell-free DNA, subsequent assessment with comparison to previously analyzed patient specimens to evaluate for MRD
| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
Aetna
| Professional | $556.14 | $587.91 | $651.48 | |
BCBS
| Facility | $0.02 | $1,629.15 | $1,839.24 | |
United
| Professional | $333.69 | $476.69 | $1,145.89 |